The Spectranetics

Spectranetics Corporation, headquartered in Colorado Springs, develops and manufactures single-use medical devices for minimally invasive cardiovascular procedures. The company specializes in products for managing arterial blockages in the heart and legs, as well as for the removal of cardiac leads from pacemakers and defibrillators. Its vascular intervention portfolio includes various catheters—such as laser and aspiration catheters, scoring balloon catheters, and drug-coated balloon catheters—alongside laser systems used in these procedures. Key products feature Quick-Cross support catheters and ELCA Laser Ablation Catheters for crossing and vessel preparation. Additionally, the company offers solutions for lead management and the Stellarex DCB platform designed for treating peripheral arterial disease. Spectranetics markets its products directly and through distributors across multiple regions, including the United States, Europe, and Asia. Founded in 1984, the company emphasizes innovation and continues to develop advanced tools and techniques to enhance the effectiveness of cardiovascular interventions.